Octahydro-2-H-naphtho[1,2-F] indole4-carboxamide derivatives as selective glucocorticoid receptor modulators

Details for Australian Patent Application No. 2003270783 (hide)

International Classifications

Event Publications

15 January 2004 Complete Application Filed

Priority application(s): 60/412,231 20.09.02 US; 60/476,079 05.06.03 US

20 May 2004 Application Open to Public Inspection

Published as AU-B-2003270783

24 December 2009 Application Accepted

Published as AU-B-2003270783

21 January 2010 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp.

28 January 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 24 Dec 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

20 May 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 24 Dec 2009

27 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.